A dose-ranging study to confirm the reduction effect of plant extract on body fat. -Randomized, double-blind, placebo-controlled parallel group study
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000052954
- Lead Sponsor
- ew drug research center, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 75
Not provided
1) Subjects who are under treatment or have a history of severe illness in the heart, liver, kidney, digestive organs or other organs 2) Subjects who are under treatment of dyslipidemia, high blood pressure, or diabetes 3) Subjects who received medication treatment or surgery due to serious illness or injury within 1 month from the start of this study 4) Subjects who regularly use health foods and supplements affecting this study 5) Possible pregnancy, pregnancy, and lactation 6) Heavy drinkers, excessive smokers 7) Subjects who have experienced feel bad mood by blood collection 8) Subjects with systolic blood pressure less than 90 mmHg 9) Subjects who donated 200 mL or more of blood within 1 month from the start of this study or those who plan to do so during this study 10) Subjects who have been diagnosed with chronic constipation 11) Shift workers or late-night workers 12) Subjects who plan business trip or trip on average more than 10 days per month 13) Subjects who may have allergy to the ingredients contained in the test food 14) Subjects who are participating in other clinical trials, those who plan to participate during this study, and those within 1 month after the trial in which they participated 15) Subjects whose exercise habits may change significantly, those who regularly engage in strenuous exercise and those who on a diet 16) Subjects with extremely irregular eating habits 17) Subjects with claustrophobia that interferes with CT scans, subjects with metal in the CT scan measurement site due to surgery, subjects with implanted medical devices such as cardiac pacemakers, implantable cardioverter defibrillators 18) Subjects who fail to comply with the requests to subjects during the study period 19) Subjects who are ineligible due to physician's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method